Validation of the Cognitive Telephone Screening Instruments COGTEL and COGTEL+ in Identifying Clinically Diagnosed Neurocognitive Disorder Due to Alzheimer's Disease in a Naturalistic Clinical Setting.
Mild and major neurocognitive disorder
modified Mini-Mental State Examination
telephone-based neurocognitive testing
Journal
Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863
Informations de publication
Date de publication:
2021
2021
Historique:
pubmed:
20
7
2021
medline:
27
11
2021
entrez:
19
7
2021
Statut:
ppublish
Résumé
Telephone-based neurocognitive instruments embody valuable tools in identifying cognitive impairment in research settings and lately also in clinical contexts due to the pandemic crisis. The accuracy of the Cognitive Telephone Screening Instrument (COGTEL) in detecting mild- (MiND) and major (MaND) neurocognitive disorder has not been studied yet. Comparison of the utility of COGTEL and COGTEL+, which is enriched with orientation items, with the modified Mini-Mental State Examination (3MS) in detecting MiND and MaND due to Alzheimer's disease (AD) and assessment of the impact of COGTEL face-to-face-versus telephone administration on individual performance. The study included 197 cognitively intact individuals (CI), being at least 45 years old, 95 and 65 patients with MiND and MaND due to AD, respectively. In 20 individuals COGTEL was administered both in face-to-face and telephone sessions. Statistical analyses included proportional odds logistic regression models, stratified repeated random subsampling used to recursive partitioning to training and validation set (70/30 ratio), and an appropriate F-test. All studied instruments were significant predictors of diagnostic outcome, but COGTEL+ and 3MS explained more variance relative to the original COGTEL. Except for the validation regression models including COGTEL in which the average misclassification error slightly exceeded 15%, in all other cases the average misclassification errors (%) were lower than 15%. COGTEL administration modality was not related to systematic over- or underestimation of performance on COGTEL. COGTEL+ is a valuable instrument in detecting MiND and MaND and can be administered in face-to-face or telephone sessions.
Sections du résumé
BACKGROUND
Telephone-based neurocognitive instruments embody valuable tools in identifying cognitive impairment in research settings and lately also in clinical contexts due to the pandemic crisis. The accuracy of the Cognitive Telephone Screening Instrument (COGTEL) in detecting mild- (MiND) and major (MaND) neurocognitive disorder has not been studied yet.
OBJECTIVE
Comparison of the utility of COGTEL and COGTEL+, which is enriched with orientation items, with the modified Mini-Mental State Examination (3MS) in detecting MiND and MaND due to Alzheimer's disease (AD) and assessment of the impact of COGTEL face-to-face-versus telephone administration on individual performance.
METHODS
The study included 197 cognitively intact individuals (CI), being at least 45 years old, 95 and 65 patients with MiND and MaND due to AD, respectively. In 20 individuals COGTEL was administered both in face-to-face and telephone sessions. Statistical analyses included proportional odds logistic regression models, stratified repeated random subsampling used to recursive partitioning to training and validation set (70/30 ratio), and an appropriate F-test.
RESULTS
All studied instruments were significant predictors of diagnostic outcome, but COGTEL+ and 3MS explained more variance relative to the original COGTEL. Except for the validation regression models including COGTEL in which the average misclassification error slightly exceeded 15%, in all other cases the average misclassification errors (%) were lower than 15%. COGTEL administration modality was not related to systematic over- or underestimation of performance on COGTEL.
CONCLUSION
COGTEL+ is a valuable instrument in detecting MiND and MaND and can be administered in face-to-face or telephone sessions.
Identifiants
pubmed: 34275904
pii: JAD210477
doi: 10.3233/JAD-210477
pmc: PMC8461705
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
259-268Références
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
Arch Clin Neuropsychol. 2020 Nov 19;35(8):1240-1248
pubmed: 33124648
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
JMIR Ment Health. 2020 Aug 28;7(8):e21108
pubmed: 32658857
Curr Alzheimer Res. 2020;17(5):460-471
pubmed: 32589557
J Environ Manage. 2019 Oct 1;247:371-384
pubmed: 31254753
Arch Clin Neuropsychol. 2002 Feb;17(2):171-7
pubmed: 14589746
Dement Geriatr Cogn Disord. 2010;29(5):448-56
pubmed: 20502019
Stat Med. 2005 Oct 15;24(19):3019-35
pubmed: 16149128
J Alzheimers Dis. 2017;58(1):69-78
pubmed: 28372331
J Int Neuropsychol Soc. 2017 Oct;23(9-10):778-790
pubmed: 29198281
Dement Geriatr Cogn Disord. 2010;30(4):309-16
pubmed: 20881396
Nat Rev Neurol. 2021 Feb;17(2):69-70
pubmed: 33408384
J Neural Transm (Vienna). 2018 Feb;125(2):193-201
pubmed: 29143217
Int J Geriatr Psychiatry. 2006 Feb;21(2):158-62
pubmed: 16416470
J Geriatr Psychiatry Neurol. 2019 Sep;32(5):265-274
pubmed: 31159629
Neural Comput. 2000 Oct;12(10):2385-404
pubmed: 11032039
Mayo Clin Proc. 2014 Oct;89(10):1452-9
pubmed: 25282431
Int Psychogeriatr. 2020 Jun;32(6):689-691
pubmed: 32616115
BMC Geriatr. 2020 Jul 11;20(1):241
pubmed: 32652945
J Alzheimers Dis. 2017;58(2):425-434
pubmed: 28453478
Sci Rep. 2015 Dec 04;5:17657
pubmed: 26634694
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):6008-10
pubmed: 19307569
BMC Geriatr. 2017 Apr 28;17(1):99
pubmed: 28454521
Neuropsychol Rev. 1991 Jun;2(2):179-201
pubmed: 1844708
Int Psychogeriatr. 2019 May;31(5):693-701
pubmed: 30021667
Arch Clin Neuropsychol. 2020 Nov 19;35(8):1215-1233
pubmed: 33106856
Front Psychiatry. 2020 Sep 15;11:577629
pubmed: 33101090
Atten Percept Psychophys. 2013 Oct;75(7):1507-19
pubmed: 23864263
Neurobiol Aging. 2018 Oct;70:308-324
pubmed: 29754747
Psychosomatics. 2016 Mar-Apr;57(2):208-16
pubmed: 26892326
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Genome Med. 2015 Oct 20;7:106
pubmed: 26482651
Dement Geriatr Cogn Dis Extra. 2017 Oct 3;7(3):339-345
pubmed: 29118786
J Psychol. 2007 Mar;141(2):147-70
pubmed: 17479585